Ergomed plc announced that it has further strengthened its Executive Management Team with two significant senior appointments. In line with the continued strengthening of management team and commitment to maximising the potential of technology across the business, Michael Spiteri has been appointed as Chief Transformation and Technology Officer (CTTO). As a result of the appointment, Michael has stepped down as a Non-Executive Director with immediate effect.

Michael has over 30 years' experience working in information technology and digital transformation with companies including Santander, Elixirr Partners, PwC, Accenture and IBM. He was previously Global Head of Insurance Transformation and Innovation, HSBC Life and Partnerships at HSBC. Michael specialises in helping organizations implement technology that transforms their business and operating models and, since joining Ergomed's Board of Directors in 2018, has helped Ergomed develop its capabilities across digital, automation and machine learning.

In addition, Jonathan Curtain has been appointed as Deputy Chief Financial Officer. Jonathan has extensive life sciences industry experience, having spent 13 years with ICON plc, a leading global CRO business listed on the NASDAQ with a market capitalization of $16 billion. Most recently, he was the Senior Vice President of Corporate and Commercial Finance, where he had a broad range of responsibilities including financial reporting, acquisitions and post-acquisition integration, debt and equity fundraising, treasury and overall financial management.

During his time with ICON, he has also led the Investor Relations function and played a key role in transactions worth over $13.5 billion including most recently the $12 billion acquisition by ICON of PRA Health Sciences Inc. Jonathan has over 20 years' experience as a Chartered Account after receiving his ACA qualification at KPMG.